WebApr 10, 2024 · 2 Wall Street analysts have issued 12 month price objectives for Biotricity's stock. Their BTCY share price forecasts range from $2.00 to $4.00. On average, they anticipate the company's share price to reach $3.00 in the next twelve months. This suggests a possible upside of 522.3% from the stock's current price. WebApr 5, 2024 · Biotricity Inc is a medical technology company that focuses on biometric data monitoring solutions. It aims to deliver remote monitoring solutions to the healthcare & consumer markets, with a...
Biotricity (Nasdaq:BTCY) - Stock Price, News & Analysis - Simply …
WebLegal Name Biotricity, Inc. Stock Symbol NASDAQ:BTCY. Company Type For Profit. Contact Email [email protected]. Phone Number +118005904155. Biotricity is a medical technology company focused … WebBiotricity is a biomass processing CHP power station developer. We have sought and achieved grid connection, planning permission and technology for our initial site in … shroud tool
Remote Monitoring for Cardiac Patients: Interview with Dr.
WebAug 27, 2024 · Doctors and patients trust Biotricity's unparalleled standard for preventive & personal care, including diagnostic and post-diagnostic products for chronic conditions. The company develops... WebBiotricity is a medical technology company committed to improving healthcare by developing solutions that aid chronic disease prevention and management. Biotricity’s premier product is Bioflux, an ECG monitoring … WebFeb 9, 2024 · Biotricity to Launch Commercial Sales of Its Disruptive Cardiac Monitoring Device, Biotres in April 2024. 3/22/2024. Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, will officially launch the commercial sales of its FDA cleared, wireless wearable cardiac monitoring device, Biotres, in April 2024. shroud thesaurus